Astrana Health (ASTH) Cash from Financing Activities (2011 - 2026)

Astrana Health (ASTH) has 16 years of Cash from Financing Activities data on file, last reported at -$16.0 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 63.87% year-over-year to -$16.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $597.6 million (up 3986.54% YoY) and the FY2025 annual result came in at $569.3 million, up 321.28% from the prior year.
• Cash from Financing Activities advanced to -$16.0 million in Q1 2026 per ASTH's latest filing, from -$26.3 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $648.5 million in Q3 2025, with the low at -$44.2 million in Q1 2025.
• Average Cash from Financing Activities over 5 years is $39.5 million, with a median of -$3.2 million recorded in 2024.
• Year-over-year, Cash from Financing Activities sank 1434.4% in 2023 and soared 20428.87% in 2025.
• Astrana Health's Cash from Financing Activities stood at $5.9 million in 2022, then soared by 104.28% to $12.0 million in 2023, then tumbled by 227.3% to -$15.3 million in 2024, then sank by 72.51% to -$26.3 million in 2025, then surged by 39.4% to -$16.0 million in 2026.
• Business Quant data shows ASTH's Cash from Financing Activities at -$16.0 million in Q1 2026, -$26.3 million in Q4 2025, and $648.5 million in Q3 2025.